Oncology Drug Discovery Services
Oncology discovery services combining advanced in vitro and in vivo cancer models to support anti-cancer drug discovery across small molecule, biologic, and immuno-oncology programs.
BioDuro provides more than 400 oncology models spanning syngeneic, CDX, PDX, orthotopic, metastatic, and humanized immune system platforms. Supported by integrated in vitro biology, translational research, and pharmacology expertise, our teams help evaluate therapeutic efficacy, investigate tumor biology, and advance oncology drug discovery programs.
In Vitro Oncology Models
Support oncology discovery through validated 2D and 3D cellular platforms designed to evaluate anti-cancer activity and biological responses.
- 2D Cellular Assays
- 3D Tumor Models
- Cancer Cell Lines
- Drug Resistant Models
In Vivo Tumor Models
Evaluate therapeutic efficacy using established in vivo oncology models across multiple tumor settings.
- CDX Models
- Orthotopic Models
- Metastatic Models
- PDX Models
Immuno-Oncology Models
Investigate immune-mediated anti-tumor responses through specialized immuno-oncology and syngeneic tumor models.
- Syngeneic Models
- Humanized Immune Models
- Immune Response Studies
- Translational Oncology Research
CDX & PDX Models
- 180+ validated CDX models
- Orthotopic and metastatic models
- Luciferase-labeled models
Humanized Immune Models
- PBMC-humanized models
- GM-humanized models
- CAR-T evaluation
Syngeneic Tumor Models
- Immuno-oncology studies
- Immune response evaluation
- Translational oncology research
Biomarker & Imaging Analysis
- Histology & IHC
- Flow cytometry
- Live tumor imaging
